12 results for author:"Sugai K." in Literature citations
Results Customize
› Repeat search in UniProtKB (218)
| Inflammatory changes in infantile-onset LMNA-associated myopathy. Komaki H., Hayashi Y.K., Tsuburaya R., Sugie K., Kato M., Nagai T., Imataka G., Suzuki S., Saitoh S., Asahina N. et al. Neuromuscul. Disord. 21:563-568(2011) · Mapped (8) |
| Genotyping and phylogenetic analysis of the major genes in respiratory syncytial virus isolated from infants with bronchiolitis. Goto-Sugai K., Tsukagoshi H., Mizuta K., Matsuda S., Noda M., Sugai T., Saito Y., Okabe N., Tashiro M., Kozawa K. et al. Jpn. J. Infect. Dis. 63:393-400(2010) · UniProtKB (62) |
| CYP2C8 haplotype structures and their influence on pharmacokinetics of paclitaxel in a Japanese population. Saito Y., Katori N., Soyama A., Nakajima Y., Yoshitani T., Kim S.R., Fukushima-Uesaka H., Kurose K., Kaniwa N., Ozawa S. et al. Pharmacogenet. Genomics 17:461-471(2007) · Mapped (5) |
| Periaxin mutation in Japanese patients with Charcot-Marie-Tooth disease. Otagiri T., Sugai K., Kijima K., Arai H., Sawaishi Y., Shimohata M., Hayasaka K. J. Hum. Genet. 51:625-628(2006) · Mapped (1) |
| Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Soyama A., Saito Y., Hanioka N., Maekawa K., Komamura K., Kamakura S., Kitakaze M., Tomoike H., Ueno K., Goto Y. et al. Drug Metab. Pharmacokinet. 20:24-33(2005) · UniProtKB (1) · Mapped (1) |
| Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients. Nakajima Y., Saito Y., Shiseki K., Fukushima-Uesaka H., Hasegawa R., Ozawa S., Sugai K., Katoh M., Saitoh O., Ohnuma T. et al. Eur. J. Clin. Pharmacol. 61:25-34(2005) · Mapped (3) |
| Twenty-six novel single nucleotide polymorphisms and their frequencies of the NR1I3 (CAR) gene in a Japanese population. Ikeda S., Kurose K., Ozawa S., Sai K., Hasegawa R., Komamura K., Ueno K., Kamakura S., Kitakaze M., Tomoike H. et al. Drug Metab. Pharmacokinet. 18:413-418(2003) · UniProtKB (1) |
| Five novel single nucleotide polymorphisms in the EPHX1 gene encoding microsomal epoxide hydrolase. Shiseki K., Itoda M., Saito Y., Nakajima Y., Maekawa K., Kimura H., Goto Y., Saitoh O., Katoh M., Ohnuma T. et al. Drug Metab. Pharmacokinet. 18:150-153(2003) · UniProtKB (1) |
| Eleven novel single nucleotide polymorphisms in the NR1I2 (PXR) gene, four of which induce non-synonymous amino acid alterations. Koyano S., Kurose K., Ozawa S., Saeki M., Nakajima Y., Hasegawa R., Komamura K., Ueno K., Kamakura S., Nakajima T. et al. Drug Metab. Pharmacokinet. 17:561-565(2002) · UniProtKB (1) |
| Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes. Murayama N., Soyama A., Saito Y., Nakajima Y., Komamura K., Ueno K., Kamakura S., Kitakaze M., Kimura H., Goto Y. et al. J. Pharmacol. Exp. Ther. 308:300-306(2004) · UniProtKB (1) |
| Molecular genetic study in Japanese patients with Alexander disease: a novel mutation, R79L. Shiroma N., Kanazawa N., Kato Z., Shimozawa N., Imamura A., Ito M., Ohtani K., Oka A., Wakabayashi K., Iai M. et al. Brain Dev. 25:116-121(2003) · Mapped (7) |
| Diagnosis of Alexander disease in a Japanese patient by molecular genetic analysis. Shiroma N., Kanazawa N., Izumi M., Sugai K., Fukumizu M., Sasaki M., Hanaoka S., Kaga M., Tsujino S. J. Hum. Genet. 46:579-582(2001) · Mapped (7) |